Coma and Related Disorders of Consciousness
Coma and Related Disorders of Consciousness
Coma and Related Disorders of Consciousness
Consciousness
Dr. Enrique De La Mora Glasker
coma
Reduced alertness and responsiveness
represents a continuum that in severest form
, a deep sleeplike state from which the
patient cannot be aroused.
Stupor
Lesser degrees of unarousability in which
the patient can be awakened only by
vigorous stimuli, accompanied by motor
behavior that leads to avoidance of
uncomfortable or aggravating stimuli.
Drowsiness
which is familiar to all persons, simulates
light sleep and is characterized by easy
arousal and the persistence of alertness for
brief periods.
Drowsiness and stupor
Cardiac arrest
head injuries
Akinetic mutism
Partially or fully awake patient who is able to
form impressions and think but remains immobile
and mute, particularly when unstimulated.
Causes: damage in the regions of the medial
thalamic nuclei, the frontal lobes (particularly
situated deeply or on the orbitofrontal surfaces), or
from hydrocephalus.
Abulia
Mental and physical slowness and lack of
impulse to activity that is in essence a mild
form of akinetic mutism.
with the same anatomic origins.
Catatonia
Hypomobile and mute syndrome associated with a
major psychosis.
patients appear awake with eyes open but make no
voluntary or responsive movements, although they
blink spontaneously, swallow, and may not appear
distressed.
Eyes are half-open as if the patient is in a fog or
light sleep.
NO clinical evidence of brain damage.
Locked-in state
describes a pseudocoma in which an awake
patient has no means of producing speech
or volitional limb, face, and pharyngeal
movements in order to indicate that he or
she is awake, but vertical eye movements
and lid elevation remain unimpaired, thus
allowing the patient to signal. Such
individuals have written entire treatises
using Morse code
Locked-in state
Infarction or hemorrhage of the ventral
pons, which transects all descending
corticospinal and corticobulbar pathways, is
the usual cause
Anatomy and Physiology of
Unconsciousness
Cerebral cortex
Respiratory pattern
A.- PUPILLARY LIGHT RESPONSES:
Simmetrically reactive round pupils: Exclude
midbrain
damage.
(2 to 5 mm )
pupils: herniation or
anticholinergic
drugs toxicity.
Reactive bilaterally small but not pin-
point (1 to 2.5 mm): Metabolic
encephalopathy,
deep bilateral
hemispheral
lesions as
hydrocephalus or
thalamic
hemorrhage
Ocular Movements
Abducted eye at rest, plus ipsi Medial rectus paresis due to III nerve
lateral pupilary enlargement : dysfunction.
Shallow, slow, well-timed regular Suggest metabolic or drug depression.
Breathing:
Rapid, deep (Kussmaul) breathing: Metabolic acidosis or
ponto- mesencephalic lesions.
Cheyne-Stokes breathing, with light Mild bihemispherical damage
or
Coma: metabolic supression.
Toxicologic analysis
Brain Death
Neurological examination
EEG
Radionuclide brain scanning, cerebral
angiography, or transcranial Doppler
measurements may also be used to
demonstrate the absence of cerebral blood
flow
TREATMENT FOR THE
PATIENT IN COMA.
1.- The treatment must be instituted
inmediately even when there is no a certain
diagnosis.
The inmediate goal is the prevention of
further nervous system damage.
2.- Diagnostic procedures and general
treatment mus be performed simultaneously
and to install the specific treatment when the
etiology is known.
TREATMENT FOR THE
PATIENT IN COMA.
A.- Permeable airway. Oxygen supply through
nasal fossae to endotraqueal intubation..
B.- Politrauma patient’s evaluation. Stabilize the neck
and the rest of the vertebral colum.
C.- Establish an intravenous access. Water
administration carefully monitored.
D.- Maintain the body temperature the closest to the
normal values as possible.
TREATMENT FOR THE
PATIENT IN COMA.
E.- I.V. administration of 50 ml of 50%
glucose.
F.- Administrate thiamine in malnourished and
alcoholic patients. 10 mg I.V. and 100 mg
I.M. /day /3 days.
G.- Naloxone (0.4 to 0.8 mg) or flumazenil
(0.5 to 1 mg) I.V administration
H.- Appropriate treatment of intracraneal
hypertension and seizures.
TREATMENT FOR THE
PATIENT IN COMA.
I.- General measures for the unmovable patient.
Appropriate nutrition and hydration.
Posture changes every two hours.
Mobilization of joints.
Ocular metilcelulose drops, 1 every 4 hours.
I.V. ranitidine 50 mg every 8 hours, or 300 mg in
250 ml of 5% dextrose in 24 hours; or sucralfate 1 g
per nasogatric tube every 6 hours.
S.C. Heparin, 5000 U every 12 hours.
Urinary tract care.
J.- Etiologic treatment.